Intervention

zoledronic acid

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 44 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials44
Recruiting0
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

44 shown
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidNCT01409811 · 2012-09-14
TERMINATED
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsNCT01194440 · 2011-02-01
COMPLETED
Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer PatientsNCT01099436 · 2010-04-01
COMPLETED
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung CancerNCT01004510 · 2009-11-01
TERMINATED
Extended Endocrine Therapy for Premenopausal Women With Breast CancerNCT00903162 · 2009-05-01
COMPLETED
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206 · 2009-03-01
COMPLETED
S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307NCT00873808 · 2008-10-01
WITHDRAWN
Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone MetastasesNCT00685646 · 2008-05-01
COMPLETED
Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer PatientsNCT00912938 · 2007-12-01
UNKNOWN
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerNCT00365105 · 2006-07-11
COMPLETED
ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerNCT00415779 · 2006-07-01
COMPLETED
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast CancerNCT00436917 · 2006-04-01
COMPLETED
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate CancerNCT00321620 · 2006-04-01
COMPLETED
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneNCT00458796 · 2006-03-01
TERMINATED
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerNCT00326820 · 2006-01-01
UNKNOWN
Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesNCT00588913 · 2006-01-01
COMPLETED
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases PalliationNCT00264420 · 2005-12-01
COMPLETED
Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving LetrozoleNCT00376740 · 2005-09-01
COMPLETED
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.NCT00127205 · 2005-07-01
COMPLETED
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyNCT00554918 · 2005-02-01
COMPLETED
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung CancerNCT00265200 · 2005-02-01
TERMINATED
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerNCT00107263 · 2005-01-01
COMPLETED
Non-small Cell Lung Cancer RegistryNCT00099541 · 2004-11-01
COMPLETED
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisNCT00171639 · 2004-06-01
COMPLETED
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityNCT00114270 · 2004-05-01
COMPLETED
Non-small Cell Lung Cancer Study US75 (Z-PACT)NCT00086268 · 2004-04-01
COMPLETED
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.NCT00412022 · 2004-03-01
UNKNOWN
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesNCT00079001 · 2004-01-01
COMPLETED
A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyNCT00087659 · 2003-12-01
COMPLETED
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone MetastasisNCT00241111 · 2003-09-01
COMPLETED
Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate CancerNCT00520052 · 2003-08-01
COMPLETED
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerNCT00072020 · 2003-08-01
UNKNOWN
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyNCT00063609 · 2003-04-01
COMPLETED
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerNCT00226954 · 2003-03-01
TERMINATED
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen DeprivationNCT00058188 · 2003-03-01
TERMINATED
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesNCT00060138 · 2002-11-01
COMPLETED
Zoledronate and BMS-275291 in Treating Patients With Prostate CancerNCT00039104 · 2002-04-01
COMPLETED
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast CancerNCT00049452 · 2001-12-01
COMPLETED
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast CancerNCT00022087 · 2001-12-01
COMPLETED
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone LesionsNCT00029224 · 2001-10-01
COMPLETED
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate CancerNCT00004928 · 1999-10-01
COMPLETED
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No SymptomsNCT00005073 · 1999-09-01
TERMINATED
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidNCT00295646 · 1999-06-01
COMPLETED
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneNCT00003884 · 1998-08-01
COMPLETED

Common conditions

Breast Cancer19Prostate Cancer12Metastatic Cancer10Osteoporosis7Pain5Hypercalcemia of Malignancy4Lung Cancer3Bone Metastases2Estrogen Receptor-positive Breast Cancer2Progesterone Receptor-positive Breast Cancer2Adenocarcinoma of the Prostate1Breast Adenocarcinoma1Carcinoma, Non-Small Cell Lung1Carcinoma, Small Cell Lung1DS Stage I Plasma Cell Myeloma1DS Stage II Plasma Cell Myeloma1Ductal Carcinoma in Situ1Invasive Ductal Breast Carcinoma1Kidney Cancer1Malignant Pleural Effusion1Metastases1Metastatic Breast Cancer1Metastatic Malignant Neoplasm to the Bone1Metastatic Prostate Cancer1Multiple Myeloma1

Trial status mix

COMPLETED32
TERMINATED7
UNKNOWN4
WITHDRAWN1

Phase mix

PHASE320
PHASE29
NA6
PHASE15
PHASE45
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.